Literature DB >> 6859831

Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake.

S M Mates, L Patel, H R Kaback, M H Miller.   

Abstract

The electrical potential (delta psi) across the cytoplasmic membranes of Staphylococcus aureus cells growing under aerobic and anaerobic conditions was determined by measuring the equilibrium distribution of [3H]tetraphenyl phosphonium. In conjunction, gentamicin uptake and killing were studied in the same cells under identical conditions. Under aerobic conditions, delta psi was -169 mV, gentamicin uptake was readily demonstrable, and the number of viable cells decreased by almost four orders of magnitude in the presence of antibiotic. In contrast, delta psi was -142 mV anaerobically, gentamicin uptake was essentially nonexistent, and the aminoglycoside had no effect on viability. Remarkably, when the ionophore nigericin was added under anaerobic conditions, delta psi increased to the level observed aerobically, gentamicin uptake tripled to about 18% of the aerobic level, and viability decreased by one order of magnitude. The results are consistent with other observations (Mates et al., Proc. Natl. Acad. Sci. U.S.A. 79:6693-6697, 1982), indicating that the relationship between delta psi and gentamicin uptake is gated, and suggest that diminution of delta psi may be an important factor in aminoglycoside resistance under anaerobic conditions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859831      PMCID: PMC184693          DOI: 10.1128/AAC.23.4.526

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Uptake of 14C-streptomycin by some microorganisms and its relation to their streptomycin sensitivity.

Authors:  R HANCOCK
Journal:  J Gen Microbiol       Date:  1962-07

2.  The measurement of membrane potential and deltapH in cells, organelles, and vesicles.

Authors:  H Rottenberg
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis.

Authors:  L E Bryan; S K Kowand; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

4.  The electrochemical gradient of protons and its relationship to active transport in Escherichia coli membrane vesicles.

Authors:  S Ramos; S Schuldiner; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

Review 5.  Transport across isolated bacterial cytoplasmic membranes.

Authors:  H R Kaback
Journal:  Biochim Biophys Acta       Date:  1972-08-04

6.  Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome c552 and nitrate reductase.

Authors:  L E Bryan; T Nicas; B W Holloway; C Crowther
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

7.  Mechanisms of aminoglycoside resistance of anaerobic bacteria and facultative bacteria grown anaerobically.

Authors:  L E Bryan; S Kwan
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

8.  Membrane potential and gentamicin uptake in Staphylococcus aureus.

Authors:  S M Mates; E S Eisenberg; L J Mandel; L Patel; H R Kaback; M H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

9.  Relation of aerobiosis and ionic strength to the uptake of dihydrostreptomycin in Escherichia coli.

Authors:  B D Campbell; R J Kadner
Journal:  Biochim Biophys Acta       Date:  1980-11-05

10.  Proton motive force in growing Streptococcus lactis and Staphylococcus aureus cells under aerobic and anaerobic conditions.

Authors:  E R Kashket
Journal:  J Bacteriol       Date:  1981-04       Impact factor: 3.490

  10 in total
  28 in total

1.  Resistance studies with daptomycin.

Authors:  J A Silverman; N Oliver; T Andrew; T Li
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Defective gamma subunit of ATP synthase (F1F0) from Escherichia coli leads to resistance to aminoglycoside antibiotics.

Authors:  R Humbert; K Altendorf
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

Review 3.  The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.

Authors:  C S Lewin; I Morrissey; J T Smith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 4.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

5.  Sulfide Protects Staphylococcus aureus from Aminoglycoside Antibiotics but Cannot Be Regarded as a General Defense Mechanism against Antibiotics.

Authors:  Julia Weikum; Niklas Ritzmann; Nils Jelden; Anna Klöckner; Sebastian Herkersdorf; Michaele Josten; Hans-Georg Sahl; Fabian Grein
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  Effect of NaCl supplementation of Mueller-Hinton broth on susceptibility of staphylococci to aminoglycosides.

Authors:  J M Campos; C J Gill; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

Review 7.  Mechanism of bactericidal action of aminoglycosides.

Authors:  B D Davis
Journal:  Microbiol Rev       Date:  1987-09

Review 8.  Bacterial uptake of aminoglycoside antibiotics.

Authors:  H W Taber; J P Mueller; P F Miller; A S Arrow
Journal:  Microbiol Rev       Date:  1987-12

Review 9.  "It Takes a Village": Mechanisms Underlying Antimicrobial Recalcitrance of Polymicrobial Biofilms.

Authors:  Giulia Orazi; George A O'Toole
Journal:  J Bacteriol       Date:  2019-12-06       Impact factor: 3.490

10.  Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity.

Authors:  W L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.